Targeted Therapies EXAM 2 Flashcards

(69 cards)

1
Q

EGFR is a protein that is often found in which type of cells?

A

epithelial cells
-Skin
-GI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name an example of a unique toxicity of targeted therapy in epithelial cells

A

blocking EGF-receptors on epithelial cells on the skin and the GI

-rash (skin)
-diarrhea (GI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are EGF receptors activated in healthy epithelial cells?

A

by phosphorylation (PI3K)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the pathways that is activated by phosphorylation in epithelial cells.

A

phosphorylation of EGF-R

  1. RAS -> Raf -> MEK -> ERK (they phosphorylate each other) -> gene activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the alternative pathway that promotes cell growth in epithelial cells?

A

AKT phosphorylates mTOR
-> gene activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens with EGFR in mutated epithelial cells that cause cancer?

A
  1. overexpression of Epidermal Growth Factor Receptor (EGFR)
    -> more EGF ligands bind to EGF-R
  2. mutation of EGFR (always ON)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which cancer type is predominantly affected by overexpression of EGFR?

A

head and neck cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which type of drugs block EGFR outside of the cell? Name two drugs.

A

Monoclonal antibodies

-Cetuximab (Erbitux)
-panitumumab (Vectibix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MAbs that target EGF-R only work in which genotype in colon cancer treatment? Why?

A

K-RAS and N-RAS (wild-type)

RAS is downstream and if mutated (always ON) it is not affected by EGF-R

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the On-target toxicities of mAbs targeting EGF-R?

!!!

A

-Infusion reactions: esp. cetuXimab (bc foreign proteins)

On-target: !!!!
-Acne-like rash
-Diarrhea

-Hypomagnesemia (EGF-R reabsorbs magnesium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which MAb that targets EGF-R is preferred to reduce infusion reaction in cancer treatment?

A

Panitumumab (Vectibix)

mumab = human origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which type of drug targets EGF-R inside the cell?

A

Tyrosine-Kinase inhibitors

-blocking the phosphorylation
EGF-R is always ON (phosphorylated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name some of the Tyrosine-Kinase inhibitors

A

-inib

erlotinib
gefitinib
afatinib
lapatinib (also target HER2)
lazertininb
osimertinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which commonly used TKI has a higher affinity to mutated EGFR (mEGFR)?

A

-osimertinib (newer generation)

less diarrhea and rash compared to the other ones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the unique toxicity of TKI (tyron kinase inhibitor)?

A

acne-like rash
diarrhea

we don’t see much infusion reaction (since it is PO) and hypomagnesemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HER2 receptors often dimerize with which other receptors on epithelial cells? What makes it dangerous in cancer?

A

-HER2 can dimerize with itself and EGF-R

-HER2 doesn’t need a ligand to dimerize and be active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why is HER2 a good target for cancer drugs?

A

because it is overexpressed and can be targeted by the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

tissues and orgnas that have HER2 overexpression

A

-breast (20%)
-gastric cancer !!!
-lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the unique toxicity of HER2 mAb therapy?

A

-LVEF reduction (reversible if the drug is stopped)
-diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Which other anticancer drug causes cardiomyopathy?

REMINDER

A

Anthracyclines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Name the MAb that targets HER2.

A

-trastuzumab
-pertuzumab (only used with trastuzumab)
-Ado-trastuzumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the difference between Ado-trastuzumab (mAb)?

A

Ado- contains emtansine (Adc = antibody-drug-conjugant)

3x emtansine conjugated to the mAb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Explain the MOA of Ado-trastuzumab

A

-it binds to HER2 receptors
-it gets into the cell
-emtansine is a microtubule inhibitor causing cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What side effects are seen with Ado-trastuzumab?

A

in addition to diarrhea and reduced LVEF it has
-myelosuppression (thrombocytopenia)
-LFT
-arthralgia (joint pain)
-myalgia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Which drug is conjugated to Fam-trastuzumab deruxtecan
deruxtecan (8 compounds)
26
Deruxtecan is what type of anticancer drug?
Topoisomerase I inhibitor
27
What are the side effects we see with Fam-trastuzumab?
-reduced LVEF -diarrhea -myelosuppression (neutropenia) -ILD (interstitial lung disease, pulmonary fibrosis)
28
Which other anticancer drug causes diarrhea? REMINDER
Irinotecan (I ran to the can) Topo I inhibitor
29
What has to be monitored in patients who are treated with HER2?
monitor EF with ECHO every 3 months if EF is low -> treat the EF with an HF regimen (ACEi/ARB + BB..) when normal can use the anticancer drug again if needed
30
Which TKI targeting EGF-R also targets HER2?
-lapatinib -neratinib (need diarrhea prophylaxis: loperamide) -tucatinib but they don't work as well as the IV HER2 drugs (-zumabs) and they cause more diarrhea
31
Which anticancer drugs should NOT be given together with HER2 targeting drugs and WHY?
Anthracyclines because both cause a reduction in LVEF may give Anthracyclines after HER2 drugs (-zumabs)
32
Which protein stimulates blood vessel development in cancer cells?
VGEF (produced by the cancer cell)
33
Which mAb binds to the VGEF ligand? Does it bind intracellular or extracellular?
Bevacizumab outside of the cell
34
Which TKI binds to the VGEF-R? Does it bind Intracellular or extracellular?
sunitinib VGEF-R inhibitors are TKIs inside the cell
35
What is the brand name of Bevacizumab? !!!
Avastin
36
What are the On-target toxicities of VGEF-targeted agents? !!!
-Hypertension decreased NO -Proteinuria (maintain fenestration in glomerulus, filtering protein) -Impaired wound healing bc we block the mTOR pathway (blood supply in wound healing) -Bleeding (bc we stop angiogenesis, unfinished blood vessel that leaks) -Thromboembolic event (the body's reaction to the bleeding)
37
Why can VEGF-R inhibitors have a variety of different side effects?
because it is a multikinase inhibitor that also targets other kinases -> causing different side effects -hair discoloration -Hand-Foot syndrome -diarrhea -LFT
38
What is the difference between BRAF and Raf?
BRAF is an isoform of Raf -in the MAPKinase pathway when BRAF is mutated it is always ON
39
What is the common mutation of BRAF?
activating mutation: BRAFv600E
40
Name the BRAF TKIs
-raf-enib vemurafenib dabrafenib encorafenib sorafenib regorafenib
41
What is the On-target toxicity of BRAF TKIs?
Skin toxicities !!! -rash -photosensitivity -Hand-foot syndrome -alopecia sometimes: -non-melanoma skin cancer -SJS
42
Why does treating skin cancer with BRAF cause other skin melanomas?
cancer cells find other ways to activate MEK -increased activity of MEK in cancer cells and in healthy cells -the healthy cells cause another type of cancer (need another drug -> more toxicities)
43
Which toxicities do we see when blocking mutated BRAF?
-non-melanoma skin cancer -hyperkeratosis
44
What are the advantages and disadvantages of blocking 2 different pathways in epithelial cells? BRAF and MEK pathway
advantage: -longer disease control -fewer non-melanoma skin cancer (since we block MEK) -less skin toxicity disadvantage: more of the other toxicities since we are using 2 drugs -cardiomyopathy, fever, hepatic, ophthalmic
45
Which drug inhibtis the progression from G1 to S phase in cancer cells?
CDK 4/6 Inhibitors palbociclib ribociclib abemaciclib
46
What needs to happen in a healthy cell to progress from G1 to the S-phase?
CKD needs to phosphorylate Rb CKD inhibitor prevents that -> Cell cycle arrest
47
Name the CKD inhibitors.
-palbociclib -Ribociclib -abemaciclib
48
What are the side effects of CDK inhibitors?
Myelosuppression (palbociclib, Ribociclib) -nausea -alopecia -diarrhea -Qt prolongation
49
Which CDK inhibitor has QT prolongation as a side effect?
Ribociclib
50
Which of the CDK inhibitors is mostly associated with diarrhea?
abemaciclib
51
Why is the side effect profile of CDK inhibitors similar to "mini chemotherapy"?
Because they are sensitive to rapidly growing cells
52
What is the indication of CDK inhibitors?
breast cancer (men and women)
53
Which CDK inhibitor causes less myelosuppression and doesn't require a rest phase during cancer therapy?
abemaciclib palbociclib and ribociclib are given in weeks 1, 2, and 3 then we pause for 1 week
54
Which stimuli are part of the immune checkpoint of the immune system?
positive (needs to be there to prevent killing) -self-antigen -co-stimulus (CD-28)
55
The binding to which receptor prevents the killing of healthy cells and is used by cancer cells to hide from immune cells?
CTLA-4 PD-1/PD-L1
56
Which mAb blocks CTLA-4?
Ipilimumab (Yervoy)
57
What are the irAEs and what causes it? Unique Toxicity of Ipilimumab
because of stopping the "pedal" of the immune system -> overactivity of the immune system -colitis (inflammation of the colon) -hepatitis -dermatitis -hypothyroidism LEGS L: liver - hepatitis E: endocrinopathies - thyroid G: GI - diarrhea, colitis S: skin - dermatitis could also affect other organs: pneumonitis, nephritis, encephalitis
58
Explain PD-1 and PD-L1
if PD-L1 is expressed in a cell, it stays alive even though the antigen is foreign (danger) -cancer cells express PD-L1 to evade the immune system
59
What are the most commonly used PD-1 blocking agents?
-nivolumab -pembrolizumab
60
What are the brand names of nivolumab and pembrolizumab?
nivolumab (Opdivo) pembrolizumab (Keytruda)
61
Name PD-L1 agents not discussed in class
-atezolizumab (Tecentriq) -avelumab (Bavencio) -durvalumab (Imfinzi) -cosibelimab
62
Which drugs are used to manage the side effects of Immune Checkpoint inhibitors? (ICI)
high dose of corticosteroids, may add another immunosuppressant -prednisone and infliximab for hypothyroidism: levothyroxine
63
CD-20 are expressed in what type of immune cells?
B-cells
64
Which drug binds to CD20? What is its MOA?
Rituximab CD20 is on mutated B-cells -the antibody binds to CD20 binding to the antibody can activate cell lysis -by T-cells -by complement protein -by macrophages
65
What are the unique toxicities of Rituximab?
-infusion reactions -reactivating of Hep B virus check Hep serum !!!
66
What are the premeds for Rituximab and how do we administer the drug to check for infusion reaction?
-premeds: Tylenol and Benadryl start at a low rate and check for reactions
67
Why can we start at a higher rate with 2nd cycle of Rituximab?
because killing of the cells causes cytokine release -> causing the infusion reaction by the 2nd cycle, some of the cancer cells are killed, so there is less risk of reactions
68
What is the single mutation that causes CML?
Translocation of chromosomes 9 and 22 fused chromosome (Philadelphia chromosome) bcr-abl
69
Which drug is used for CML and what is its MOA?
Imatinib prevents ATP binding to the pocket of the BCR-ABL fusion protein (the BCR-ABL needs ATP to work)